Newsletter RSS

Mealey's Patents

  • June 30, 2025

    Federal Circuit: No Mandamus For Qualcomm, Apple On Patent Suit Transfer Bid

    WASHINGTON, D.C. — A Texas federal judge did not clearly err when denying requests from Qualcomm Inc. and Apple Inc. to transfer a patent infringement suit against them to a California federal court, a Federal Circuit U.S. Court of Appeals panel found, denying the companies’ request for a writ of mandamus.

  • June 27, 2025

    Federal Circuit: Judge Reasonably Tossed Patent Claims Against Google

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed a California federal judge’s finding that a pro se inventor’s patent infringement allegations against Google LLC failed as a matter of law because they relied on third-party modifications to Google’s product; the panel said the inventor could not point to a prior appellate win involving Apple as preclusive because it involved separate issues.

  • June 26, 2025

    Federal Circuit Says Data ‘Translation’ Patent Abstract Per Alice Test

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel agreed with a California federal judge that a technology company’s data transfer patent is directed at the abstract concept of translation, affirming the judge’s grant of judgment on the pleadings in a June 25 opinion.

  • June 26, 2025

    Federal Circuit Says PTAB Got Obviousness Of Streaming Patent Right

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel rejected a patentholder’s argument that the U.S. Patent Trial and Appeal Board (PTAB) erred when analyzing the motivation to combine prior art elements during inter partes review (IPR) proceedings concerning a patent related to adaptive bitrate streaming for media services.

  • June 24, 2025

    Federal Circuit: PTAB Erred On ‘Unexpected Results’ In GI Drug Patent Row

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel vacated a U.S. Patent Trial and Appeal Board (PTAB) decision to uphold a drugmaker’s patent on a molecule for use in gastrointestinal disorder medications, finding that the board erred in its analysis of whether the patent holder had shown that its patented product had “unexpected results” when considering whether the patent’s claims were rendered obvious by prior art references.

  • June 23, 2025

    Supreme Court Invites Government Response To Generic Drug Patent Petition

    WASHINGTON, D.C. — The U.S. Supreme Court on June 23 invited the government to express its views on a petition for a writ of certiorari filed by a bioequivalent drug manufacturer that contends that the Federal Circuit U.S. Court of Appeals was wrong to reverse a Delaware federal judge’s finding of no induced infringement in a dispute over patents related to a prescription cardiovascular medication.

  • June 20, 2025

    Federal Circuit Can’t Consider Realtek Challenge To ITC Sanctions Denial

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals lacks jurisdiction to consider Realtek Semiconductor Corp.’s appeal of the U.S. International Trade Commission’s denial of requested sanctions in a dispute over the licensing of patented products because the order was not a final determination, a panel in the appeals court held.

  • June 20, 2025

    PTAB Didn’t Consider Some Netflix Invalidity Arguments, Panel Says

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed a finding by the U.S. Patent Trial and Appeal Board (PTAB) that multiple claims in a technology company’s patent related to streaming video are invalid, but the panel said that PTAB did not fully consider arguments from streaming giant Netflix Inc. on the motivation to combine prior art references.

  • June 19, 2025

    Federal Circuit Affirms PTAB’s Obviousness Finding For Sonos Playback Patent

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on June 18 rejected arguments from Sonos Inc. that the U.S. Patent Trial and Appeal Board (PTAB) was wrong to invalidate multiple claims in its patent related to the playback of music on a device controlled by another device, affirming the board’s finding that the patent was obvious as per prior art in inter partes review (IPR) proceedings brought by Google LLC.

  • June 19, 2025

    Xerox’s User Profile Patent Invalid As Obvious, Federal Circuit Affirms

    WASHINGTON, D.C.  — A Federal Circuit U.S. Court of Appeals panel affirmed a finding from the U.S. Patent Trial and Appeal Board (PTAB) that invalidated all claims in a patent held by Xerox Corp., agreeing with PTAB that Xerox failed to show that the board incorrectly construed a claim term involving the navigation of web pages.

  • June 18, 2025

    High Court Won’t Rethink Denial Of Cert For Patent Damages Case

    WASHINGTON, D.C. — The U.S. Supreme Court rejected a petition for rehearing from the owner of a trading company whose petition for a writ of certiorari the justices denied in April, leaving in place a Federal Circuit U.S. Court of Appeals’ patent invalidity finding despite what the petitioner characterized as “two key developments.”

  • June 17, 2025

    High Court Won’t Hear Argument That Federal Circuit Imposed Rigid Patent Rule

    WASHINGTON, D.C. — The U.S. Supreme Court on June 16 rejected a patent-holder’s petition for a writ of certiorari, leaving in place a split Federal Circuit U.S. Court of Appeals panel’s decision affirming a Delaware federal judge’s grant of judgment as a matter of law (JMOL) in defendant Comcast Cable Communications LLC’s favor on accusations that it infringed on internet-based phone patents.

  • June 12, 2025

    Federal Circuit Affirms Invalidation Of CRISPR Patents As Anticipated

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on June 11 said there was no error in the U.S. Patent Trial and Appeal Board’s (PTAB) finding that all claims of a biotechnology company’s patents on gene modification are invalid; the panel said that substantial evidence supported PTAB’s finding that prior art anticipated the patents.

  • June 11, 2025

    Federal Circuit OKs PTAB Rejection Of Heart Valve Patent Invalidity Arguments

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed a U.S. Patent Trial and Appeal Board (PTAB) order that allowed Cardiovalve Ltd. to amend multiple claims in its patent, agreeing with PTAB that Edwards Lifesciences Corp. and a related entity failed to show that the claims of Cardiovalve’s heart implant patent were invalid.

  • June 10, 2025

    Federal Circuit Again Sends Sirius XM Patent Row Back To District Court

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on June 9 reversed a Delaware federal judge’s grant of summary judgment in favor of Sirius XM Radio Inc. (SXM), saying that testimony from a representative from the company raised question of material fact as to whether its behavior was driven by a lack of response from a plaintiff German research organization or business strategy.

  • June 10, 2025

    High Court Rejects Another Challenge To Federal Circuit’s 1-Word Patent Orders

    WASHINGTON, D.C. — The U.S. Supreme Court denied a medical device company’s petition for a writ of certiorari, turning away the company’s request that the court reconsider both whether the Federal Circuit U.S. Court of Appeals should stop issuing one-word affirmations of lower court decisions in patent cases and if the high court must rethink its framework for analyzing a patent’s abstractness to prevent lower court “overreach” in invalidation.

  • June 09, 2025

    3rd Circuit: Generic Drug Maker Lacked Standing To Appeal Foreign Discovery Order

    PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel found that it lacked jurisdiction over a discovery dispute in a New Jersey federal court that ultimately stems from an ongoing patent dispute in South Korea, holding that a discovery order under the federal statute that governs U.S. discovery for foreign proceedings was not an appealable final decision.

  • June 09, 2025

    Split Federal Circuit: Apple Relied On Unanalogous Prior Art Before PTAB

    WASHINGTON, D.C. — A split panel in the Federal Circuit U.S. Court of Appeals affirmed a decision from the U.S. Patent Trial and Appeal Board (PTAB) in which the board rejected Apple Inc.’s challenge to a patent related to camera-based computer interaction, holding that Apple failed to show that the prior art reference it relied on was analogous to the patent at issue.

  • June 06, 2025

    Federal Circuit: Dolby Lacked Standing To Appeal PTAB Finding In Its Favor

    WASHINGTON, D.C. — Dolby Laboratories Licensing Corp. lacked standing to appeal a procedural issue in inter partes review (IPR) proceedings where the U.S. Patent Trial and Appeal Board (PTAB) held that a petitioner failed to show the invalidity of Dolby’s patent, a Federal Circuit U.S. Court of Appeals panel ruled June 5, saying Dolby was unable to establish an injury in fact.

  • June 06, 2025

    Generic Drugmaker Tells High Court To Block Purdue’s Oxycontin Patent Petition

    WASHINGTON, D.C. — The U.S. Supreme Court should reject a petition for a writ of certiorari from Purdue Pharma LP and related entities, a generic drug manufacturer told the high court in an opposition brief that argues that Purdue is wrong to suggest that the Federal Circuit U.S. Court of Appeals has created a rigid nexus test when considering evidence of nonobviousness in a dispute over patents controlling Purdue’s Oxycontin drug.

  • June 05, 2025

    Federal Circuit: Moderna’s COVID-19 Vaccine Did Not Infringe On Patented Lipid

    WASHINGTON, D.C. — A Delaware federal judge rightly held that a COVID-19 vaccine from Moderna Inc. and related entities does not infringe on a biopharmaceutical company’s patents related to a type of lipid used in mRNA vaccines, a Federal Circuit U.S. Court of Appeals panel held June 4, saying the lipid in Moderna’s vaccine does not meet the limitations described in the pharmaceutical company’s patents.

  • June 05, 2025

    Chinese Tech Firm Waives Mandamus Response In High Court Patent Discovery Row

    WASHINGTON, D.C. — A Chinese-owned flash memory chip company opted against responding to a petition for mandamus in which an American chip maker seeks relief from a discovery order requiring it to turn over sensitive documents to its Chinese rival, filing a notice of waiver with the U.S. Supreme Court on June 4.

  • June 05, 2025

    Judge Enters $18M Judgment Against Fake Urine Maker Plaintiff In Patent Fight

    LAS VEGAS — A federal judge in Nevada entered a judgment totaling more than $18 million against the plaintiff and counter-defendant in a suit involving the alleged infringement of patents on synthetic urine that the company filed, citing the company’s failure to retain new counsel more than a year after its attorneys departed the case for lack of payment.

  • June 04, 2025

    Valve’s Patent Validity Suit Stayed While Defendants’ Counsel Seek Payment

    SEATTLE — A Washington federal judge issued a 45-day stay of video game company Valve Corp.’s complaint against a man the company accuses of being a “patent troll,” entities he controls and others while the defendants seek new counsel and the court mulls the defendants’ current counsel’s motion to withdraw from the case for lack of payment.

  • June 03, 2025

    Tech Firm Seeks Mandamus From High Court In Memory Chip Patent Discovery Row

    WASHINGTON, D.C. — A flash memory chip maker filed a petition for mandamus with the U.S. Supreme Court, seeking relief from a trial court’s discovery order requiring it to turn over sensitive documents to a Chinese rival tech firm, which the petitioner says would violate an existing protective order and implicate national security concerns.